PMC:7556165 / 71470-71679 JSONTXT

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"1966","span":{"begin":174,"end":182},"obj":"Species"},{"id":"1971","span":{"begin":68,"end":74},"obj":"Chemical"},{"id":"1974","span":{"begin":188,"end":192},"obj":"Disease"}],"attributes":[{"id":"A1966","pred":"pubann:denotes","subj":"1966","obj":"Tax:9606"},{"id":"A1974","pred":"pubann:denotes","subj":"1974","obj":"MESH:D012128"}],"text":"otentially limit its effects on local RAAS (Gheblawi et al., 2020). rhACE2 has already undergone phase 1 and 2 clinical trials in healthy volunteers and in a small cohort of patients with ARDS (Khan et al., 20"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T421","span":{"begin":188,"end":192},"obj":"Disease"}],"attributes":[{"id":"A421","pred":"mondo_id","subj":"T421","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"}],"text":"otentially limit its effects on local RAAS (Gheblawi et al., 2020). rhACE2 has already undergone phase 1 and 2 clinical trials in healthy volunteers and in a small cohort of patients with ARDS (Khan et al., 20"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1966","span":{"begin":174,"end":182},"obj":"Species"},{"id":"1971","span":{"begin":68,"end":74},"obj":"Chemical"},{"id":"1974","span":{"begin":188,"end":192},"obj":"Disease"}],"attributes":[{"id":"A1966","pred":"tao:has_database_id","subj":"1966","obj":"Tax:9606"},{"id":"A1974","pred":"tao:has_database_id","subj":"1974","obj":"MESH:D012128"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"otentially limit its effects on local RAAS (Gheblawi et al., 2020). rhACE2 has already undergone phase 1 and 2 clinical trials in healthy volunteers and in a small cohort of patients with ARDS (Khan et al., 20"}